Skip to Main Content

Paper Details

CD8<sup>+</sup> T cells contribute to survival in patients with COVID-19 and hematologic cancer.
Nat Med
333
2021
B cells, CD8, CD8 T cell, CD8 T cells, CD8+, CD8+ T cells, COVID-19, Patients, SARS, SARS-CoV, SARS-CoV-2, T cell, anti-CD20, cancer, coronavirus 2, coronavirus disease 2019, hematologic cancer, impairment of, patients, severe acute respiratory syndrome coronavirus, solid cancer
Author NameAffiliation
Heather M GianniniPerelman School of Medicine, University of Pennsylvania
Nuala J MeyerInstitute for Immunology, Perelman School of Medicine, University of Pennsylvania
Nuala J MeyerPerelman School of Medicine, University of Pennsylvania
  • 1 - 3

Datasets

Release 1.2